Published in Pathologe on May 01, 2015
Placebo-controlled, double-blind, prospective, randomized study on the effect of octreotide LAR in the control of tumor growth in patients with metastatic neuroendocrine midgut tumors: a report from the PROMID Study Group. J Clin Oncol (2009) 9.27
Lanreotide in metastatic enteropancreatic neuroendocrine tumors. N Engl J Med (2014) 6.10
ENETS Consensus Guidelines for the management of patients with liver and other distant metastases from neuroendocrine neoplasms of foregut, midgut, hindgut, and unknown primary. Neuroendocrinology (2012) 3.00
Carcinoid tumor metastatic to the breast. Arch Surg (1998) 2.71
Small cell carcinoma of the breast: a clinicopathologic and immunohistochemical study of nine patients. Am J Surg Pathol (2000) 2.63
Neuroendocrine differentiation correlates with hormone receptor expression and decreased survival in patients with invasive breast carcinoma. Histopathology (2013) 2.08
Expression of the neuroendocrine phenotype in carcinomas of the breast. Semin Diagn Pathol (2000) 1.94
ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Tumors: towards a standardized approach to the diagnosis of gastroenteropancreatic neuroendocrine tumors and their prognostic stratification. Neuroendocrinology (2009) 1.92
Solid neuroendocrine breast carcinomas: incidence, clinico-pathological features and immunohistochemical profiling. Oncol Rep (2008) 1.67
Solid neuroendocrine carcinomas of the breast: metastases or primary tumors? Breast Cancer Res Treat (2010) 1.63
Neuroendocrine differentiated breast carcinoma: imaging features correlated with clinical and histopathological findings. Eur Radiol (2002) 1.63
Neuroendocrine differentiation in carcinomas of the breast: a study of 51 cases. Semin Diagn Pathol (1989) 1.58
Invasive neuroendocrine carcinoma of the breast: a distinctive subtype of aggressive mammary carcinoma. Cancer (2010) 1.44
Expression of apocrine differentiation markers in neuroendocrine breast carcinomas of aged women. Mod Pathol (2001) 1.41
Neuroendocrine differentiation in breast cancer: established facts and unresolved problems. Semin Diagn Pathol (2010) 1.29
Invasive neuroendocrine carcinoma of the breast: a population-based study from the surveillance, epidemiology and end results (SEER) database. BMC Cancer (2014) 1.24
Neuroendocrine differentiated carcinomas of the breast: a distinct entity. Breast (2003) 1.23
Neuroendocrine carcinomas of the breast. Int J Surg (2008) 1.22
'Carcinoid' tumours of the breast: the morphological spectrum of argyrophil carcinomas. Histopathology (1982) 1.21
Invasive neuroendocrine carcinoma of the breast: a prognostic research of 107 Chinese patients. Neoplasma (2013) 1.17
Correlation of immunohistopathological expression of somatostatin receptor 2 with standardised uptake values in 68Ga-DOTATOC PET/CT. Eur J Nucl Med Mol Imaging (2008) 1.17
Tissue microarray analysis of neuroendocrine differentiation and its prognostic significance in breast cancer. Hum Pathol (2003) 1.16
Solid and mucinous varieties of so-called mammary carcinoid tumors. Am J Clin Pathol (1979) 1.16
Primary small cell neuroendocrine tumour of the breast. Eur J Obstet Gynecol Reprod Biol (2004) 1.10
[ON THE CARCINOID GROWTH FORM OF THE CARCINOMA MAMMAE, ESPECIALLY THE CARCINOMA SOLIDUM (GELATINOSUM) MAMMAE]. Frankf Z Pathol (1963) 1.05
Papillary and neuroendocrine breast lesions: the WHO stance. Histopathology (2015) 1.01
Small-cell cancer of the breast: what is the optimal treatment? A report and review of outcomes. Clin Breast Cancer (2012) 0.93
Pro-opiomelanocortin expression in a metastatic breast carcinoma with ectopic ACTH secretion. Breast J (2004) 0.88
[Metastatic breast carcinoma with neuroendocrine differentiation--its combined therapy with tamoxifen and the somatostatin analog octreotide]. Dtsch Med Wochenschr (1999) 0.82
Small cell neuroendocrine tumor of the breast in a 40 year-old woman: a case report. J Med Case Rep (2010) 0.82
Metastatic neuroendocrine tumour in the breast: a potential mimic of in-situ and invasive mammary carcinoma. Histopathology (2011) 0.81
Mucinous breast carcinomas with abundant intracytoplasmic mucin and neuroendocrine features: light microscopic, immunohistochemical, and ultrastructural study. Ultrastruct Pathol (1987) 0.81
Incidental detection of breast cancer by 68Ga-DOTATOC-PET/CT in women suffering from neuroendocrine tumours. Nuklearmedizin (2008) 0.80
Somatostatin receptors and breast cancer. Q J Nucl Med (1998) 0.79
Expression of somatostatin type-2 and -4 receptor and correlation with histological type in breast cancer. Anticancer Res (2014) 0.79
Clinical features and treatment response of solid neuroendocrine breast carcinoma to adjuvant chemotherapy and endocrine therapy. Breast J (2013) 0.79
Peptide Receptor Radionuclide Therapy (PRRT) in a Patient Affected by Metastatic Breast Cancer with Neuroendocrine Differentiation. Breast Care (Basel) (2012) 0.78
Somatostatin receptor-positive primary breast tumors: genetic, patient and tumor characteristics. Int J Cancer (1993) 0.78
Ultrastructural features of neuroendocrine differentiated carcinomas of the breast. Ultrastruct Pathol (1990) 0.77
Watery diarrhoea: an unusual manifestation of breast cancer. Neth J Med (2007) 0.77
Neuroendocrine carcinoma of the breast - a pilot study of a Danish population of 240 breast cancer patients. APMIS (2013) 0.76
Neuroendocrine ductal carcinoma in situ, comedo type, of the breast detected by screening mammography: a potentially pre-invasive counterpart of high grade neuroendocrine tumours. Pathology (2012) 0.76
Inflammatory breast cancer with refractory diarrhea: a case report. J Med Liban (2012) 0.76
The role of technetium-99m-labeled octreotide acetate scintigraphy in suspected breast cancer and correlates with expression of SSTR. Nucl Med Biol (2008) 0.76
Radiolabelled somatostatin analogs for diagnosis and radio-guided surgery of neuroendocrine breast cancer undetectable with conventional imaging procedures. Breast (2007) 0.75
Breast metastasis of ilial carcinoid tumor: case report and literature review. World J Surg Oncol (2006) 0.75
Imaging features of carcinoid tumors metastatic to the breast. Cancer Imaging (2011) 0.75
A muscle-specific insulin receptor knockout exhibits features of the metabolic syndrome of NIDDM without altering glucose tolerance. Mol Cell (1998) 8.10
Sequence and analysis of chromosome 4 of the plant Arabidopsis thaliana. Nature (1999) 5.03
The role of neuropeptide Y in the antiobesity action of the obese gene product. Nature (1995) 3.67
The psychophysics of visual search. Vision Res (2000) 2.90
Are long-chain polyunsaturated fatty acids essential nutrients in infancy? Lancet (1995) 2.73
Co-localization of HIV-1 Nef with the AP-2 adaptor protein complex correlates with Nef-induced CD4 down-regulation. EMBO J (1997) 2.57
Ki67 levels as predictive and prognostic parameters in pretherapeutic breast cancer core biopsies: a translational investigation in the neoadjuvant GeparTrio trial. Ann Oncol (2013) 2.57
Cyclooxygenase-2 expression in human esophageal carcinoma. Cancer Res (1999) 2.51
Subcellular localization of wild-type and Parkinson's disease-associated mutant alpha -synuclein in human and transgenic mouse brain. J Neurosci (2000) 2.49
Insect immunity: isolation from immune blood of the dipteran Phormia terranovae of two insect antibacterial peptides with sequence homology to rabbit lung macrophage bactericidal peptides. Proc Natl Acad Sci U S A (1989) 2.49
Assessment of the reliability of the symptoms and signs of acute appendicitis. J R Coll Surg Edinb (1991) 2.36
Switch from antagonist to agonist of the androgen receptor bicalutamide is associated with prostate tumour progression in a new model system. Br J Cancer (1999) 2.34
Croquemort, a novel Drosophila hemocyte/macrophage receptor that recognizes apoptotic cells. Immunity (1996) 2.30
The joint IAEA, EANM, and SNMMI practical guidance on peptide receptor radionuclide therapy (PRRNT) in neuroendocrine tumours. Eur J Nucl Med Mol Imaging (2013) 2.27
Survivin-deltaEx3 and survivin-2B: two novel splice variants of the apoptosis inhibitor survivin with different antiapoptotic properties. Cancer Res (1999) 2.21
Splenectomy in proximal gastric cancer: frequency of lymph node metastasis to the splenic hilus. J Surg Oncol (2001) 2.20
Differential regulation of insulin receptor substrates-1 and -2 (IRS-1 and IRS-2) and phosphatidylinositol 3-kinase isoforms in liver and muscle of the obese diabetic (ob/ob) mouse. J Clin Invest (1997) 2.11
Cognitive and motor assessment in autopsy-proven corticobasal degeneration. Neurology (2007) 2.09
A prospective, controlled study of prophylactic drainage after colonic anastomoses. Dis Colon Rectum (1987) 2.02
Activity levels of tamoxifen metabolites at the estrogen receptor and the impact of genetic polymorphisms of phase I and II enzymes on their concentration levels in plasma. Clin Pharmacol Ther (2011) 1.98
Tau protein and 14-3-3 protein in the differential diagnosis of Creutzfeldt-Jakob disease. Neurology (2002) 1.84
Acute severe isovolemic anemia impairs cognitive function and memory in humans. Anesthesiology (2000) 1.82
Selective insolubility of alpha-synuclein in human Lewy body diseases is recapitulated in a transgenic mouse model. Am J Pathol (2001) 1.81
Wooden foreign bodies in facial injury: a radiological pitfall. Int J Oral Maxillofac Surg (2001) 1.79
Prospective comparison of endoscopic ultrasound-guided fine-needle aspiration and surgical histology in upper gastrointestinal submucosal tumors. Endoscopy (2010) 1.76
[German S3-guideline "Diagnosis and treatment of esophagogastric cancer"]. Z Gastroenterol (2011) 1.74
Are radiogallium-labelled DOTA-conjugated somatostatin analogues superior to those labelled with other radiometals? Eur J Nucl Med Mol Imaging (2007) 1.72
The architecture of the interleukin-2 promoter: a reflection of T lymphocyte activation. Biochim Biophys Acta (1995) 1.67
High rate of lymph-node metastasis in submucosal esophageal squamous-cell carcinomas and adenocarcinomas. Endoscopy (2006) 1.66
Different patterns of beta-catenin expression in gastric carcinomas: relationship with clinicopathological parameters and prognostic outcome. Histopathology (2001) 1.65
Search for supersymmetry using final states with one lepton, jets, and missing transverse momentum with the ATLAS detector in √s=7 TeV pp collisions. Phys Rev Lett (2011) 1.60
Prospective comparison of 18F-FDG PET with conventional imaging modalities (CT, MRI, US) in lymph node staging of head and neck cancer. Eur J Nucl Med (1998) 1.58
Review article: somatostatin analogues in the treatment of gastroenteropancreatic neuroendocrine (carcinoid) tumours. Aliment Pharmacol Ther (2009) 1.58
MicroRNA-520/373 family functions as a tumor suppressor in estrogen receptor negative breast cancer by targeting NF-κB and TGF-β signaling pathways. Oncogene (2011) 1.57
Epithelial cells in bone marrow of breast cancer patients at time of primary surgery: clinical outcome during long-term follow-up. J Clin Oncol (2001) 1.57
[Regression of oesophageal carcinomas after neoadjuvant radiochemotherapy: criteria of the histopathological evaluation]. Pathologe (2004) 1.53
Cloning and analysis of a cecropin gene from the malaria vector mosquito, Anopheles gambiae. Insect Mol Biol (2000) 1.53
Fluorine-18 FDG positron emission tomography for imaging of hepatocellular carcinoma. Am J Gastroenterol (1999) 1.51
Regulation of tumor necrosis factor-related apoptosis-inducing ligand sensitivity in primary and transformed human keratinocytes. Cancer Res (2000) 1.51
Differential subcellular localization of functionally divergent survivin splice variants. Cell Death Differ (2002) 1.50
Push-and-pull enteroscopy using the double-balloon technique: method of assessing depth of insertion and training of the enteroscopy technique using the Erlangen Endo-Trainer. Endoscopy (2005) 1.48
Traffic-related NO2 and the prevalence of asthma and respiratory symptoms in seven year olds. Eur Respir J (1997) 1.48
The 'absent' appendix. Arch Surg (1992) 1.46
Expression of different survivin variants in gastric carcinomas: first clues to a role of survivin-2B in tumour progression. Br J Cancer (2002) 1.45
Fertility preservation in girls and adolescents before chemotherapy and radiation - review of the literature. Klin Padiatr (2011) 1.45
The effects of circulating antigen on the pharmacokinetics and radioimmunoscintigraphic properties of 99m Tc labelled monoclonal antibodies in cancer patients. J Pharm Pharm Sci (2000) 1.43
Comparison of metabolic and receptor imaging in recurrent medullary thyroid carcinoma with histopathological findings. Eur J Nucl Med (1998) 1.43
Solution structure of drosomycin, the first inducible antifungal protein from insects. Protein Sci (1997) 1.43
RNA aptamers specifically interact with the prion protein PrP. J Virol (1997) 1.43
p21/waf1/cip1 in gastric cancer: associations with histopathological subtypes, lymphonodal metastasis, prognosis and p53 status. Scand J Gastroenterol (2001) 1.42
Identification of serum angiopoietin-2 as a biomarker for clinical outcome of colorectal cancer patients treated with bevacizumab-containing therapy. Br J Cancer (2010) 1.42
Observation of a centrality-dependent dijet asymmetry in lead-lead collisions at sqrt[S(NN)] =2.76 TeV with the ATLAS detector at the LHC. Phys Rev Lett (2010) 1.41
Gene transcript analysis blood values correlate with ⁶⁸Ga-DOTA-somatostatin analog (SSA) PET/CT imaging in neuroendocrine tumors and can define disease status. Eur J Nucl Med Mol Imaging (2015) 1.41
Safety and preliminary efficacy of one month glycoprotein IIb/IIIa inhibition with lefradafiban in patients with acute coronary syndromes without ST-elevation; a phase II study. Eur Heart J (2000) 1.40
Alcohol and rhythm disturbance: the holiday heart syndrome. Herz (1996) 1.40
Measurement of dijet azimuthal decorrelations in pp collisions at sqrt(s)=7 TeV. Phys Rev Lett (2011) 1.39
Patients with Alzheimer's disease and dementia with Lewy bodies mistaken for Creutzfeldt-Jakob disease. J Neurol Neurosurg Psychiatry (2001) 1.39
[Poorly differentiated neuroendocrine carcinoma of the larynx. Diagnostic features, treatment strategy, and prognosis]. HNO (2009) 1.38
Antimicrobial peptides melittin and cecropin inhibit replication of human immunodeficiency virus 1 by suppressing viral gene expression. J Gen Virol (1998) 1.36
Preferential binding of poly(A)-binding protein 1 to an inhibitory RNA element in the human immunodeficiency virus type 1 gag mRNA. J Biol Chem (1997) 1.35
Determination of the strange-quark density of the proton from ATLAS measurements of the W→ℓν and Z→ℓℓ cross sections. Phys Rev Lett (2012) 1.34
Congenital lymphocytic choriomeningitis virus syndrome: a disease that mimics congenital toxoplasmosis or Cytomegalovirus infection. Pediatrics (1997) 1.34
Search for new particles in two-jet final states in 7 TeV proton-proton collisions with the ATLAS detector at the LHC. Phys Rev Lett (2010) 1.32
Transcription-dependent nuclear-cytoplasmic trafficking is required for the function of the von Hippel-Lindau tumor suppressor protein. Mol Cell Biol (1999) 1.30
Glucose-dependent insulinotropic polypeptide is a growth factor for beta (INS-1) cells by pleiotropic signaling. Mol Endocrinol (2001) 1.29
Purification and characterization of a scorpion defensin, a 4kDa antibacterial peptide presenting structural similarities with insect defensins and scorpion toxins. Biochem Biophys Res Commun (1993) 1.29
[Therapy of depressive states with hypericin]. ZFA (Stuttgart) (1979) 1.29
Euthyroid and primarily hypothyroid patients develop milder and significantly more asymmetrical Graves ophthalmopathy. Br J Ophthalmol (2009) 1.28
Observation of associated near-side and away-side long-range correlations in sqrt[s(NN)]=5.02 TeV proton-lead collisions with the ATLAS detector. Phys Rev Lett (2013) 1.27
Receptor PET/CT imaging of neuroendocrine tumors. Recent Results Cancer Res (2008) 1.27
Size and density of glial and neuronal cells within the cerebral neocortex of various insectivorian species. Glia (1989) 1.27
Mechanisms of tumor metastasis: cell biological aspects and clinical implications. J Cancer Res Clin Oncol (2000) 1.25
Cysteine-rich antimicrobial peptides in invertebrates. Biopolymers (1998) 1.24
Staging of gastric cancer: correlation of lymph node size and metastatic infiltration. AJR Am J Roentgenol (1999) 1.23
Drainage after cholecystectomy. Br J Surg (1985) 1.22
Enterovirus 71 isolated from China is serologically similar to the prototype E71 BrCr strain but differs in the 5'-noncoding region. J Med Virol (1995) 1.22
Clinical and molecular characterization of early T-cell precursor leukemia: a high-risk subgroup in adult T-ALL with a high frequency of FLT3 mutations. Blood Cancer J (2012) 1.22
Prognostic relevance of Tiam1 protein expression in prostate carcinomas. Br J Cancer (2006) 1.20
Immunohistochemical demonstration of enzymatically modified human LDL and its colocalization with the terminal complement complex in the early atherosclerotic lesion. Arterioscler Thromb Vasc Biol (1998) 1.20
Patterns, chunks, and hierarchies in serial reaction-time tasks. Psychol Res (2000) 1.20
Frequency of nodal metastases to the upper mediastinum in Barrett's cancer. Ann Surg Oncol (2002) 1.20
Search for dark matter candidates and large extra dimensions in events with a photon and missing transverse momentum in pp collision data at sqrt[s]=7 TeV with the ATLAS detector. Phys Rev Lett (2013) 1.19
Biological effects of imidazolium ionic liquids with varying chain lengths in acute Vibrio fischeri and WST-1 cell viability assays. Ecotoxicol Environ Saf (2004) 1.18
Rac affects invasion of human renal cell carcinomas by up-regulating tissue inhibitor of metalloproteinases (TIMP)-1 and TIMP-2 expression. J Biol Chem (2001) 1.18
ENETS Consensus Guidelines Update for the Management of Distant Metastatic Disease of Intestinal, Pancreatic, Bronchial Neuroendocrine Neoplasms (NEN) and NEN of Unknown Primary Site. Neuroendocrinology (2016) 1.17
Mechanisms of mitogenic and anti-apoptotic signaling by glucose-dependent insulinotropic polypeptide in beta(INS-1)-cells. J Endocrinol (2002) 1.17
In-vivo confocal real-time mini-microscopy in animal models of human inflammatory and neoplastic diseases. Endoscopy (2007) 1.17
Prognostic impact of p21/waf1/cip1 in colorectal cancer. Int J Cancer (2000) 1.16
Anoxia-induced up-regulation of interleukin-8 in human malignant melanoma. A potential mechanism for high tumor aggressiveness. Am J Pathol (1999) 1.16
Lymph node size and metastatic infiltration in colon cancer. Ann Surg Oncol (1999) 1.15
Staging of the neck in patients with oral cavity squamous cell carcinomas: a prospective comparison of PET, ultrasound, CT and MRI. J Craniomaxillofac Surg (2000) 1.14
Expression of MMP-2 is associated with progression and lymph node metastasis of gastric carcinoma. Histopathology (2001) 1.14